{"efta_number": "EFTA00727570", "page_count": 11, "url": "https://epstein-data.com/EFTA00727570", "pdf_url": "https://epstein-data.com/pdf/EFTA00727570.pdf", "pages": [{"efta_number": "EFTA00727570", "page_number": 0, "text_content": "Quest \nDiagnostics,\nQUEST DIAGNOSTICS INCORPORATED \nCLIENT SERUICE 800.631.1390 \nSPECIMEN INFORMATION \nSPECIMEN: X46712534 \nREQUISITION: \nCOLLECTED: 03/03/2010 \n11:50 \nRECEIUED: \n03/03/2010 \n21:07 \nREPORTED: \n03/09/2010 \n17:30 \nPATIENT INFORMATION \nEPSTEIN,JEFFREY \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: \nPHONE: 212.750.9895 \nREPORT STATUS PARTIAL \nREPRINT \nORDERING PHYSICIAN \nCLIENT INFORMATION \nT11886 \nWOODSON MERRELL, M D. \n44 E 67TH STREET \nNEW YORK. NY 10065 \n10013650 \nThe original copy of this report was printed on: 03/09/2010 at 08:16 \nPatient results contained In a facsimile or electronic \nmedical report are provided only upon the request of the \nphysician or authorized person. Facsimile or electronic \nmedical reports that are created before the final results \naro reported are considered to be INTERIM RESULTS ONLY and \nare subject to change by the laboratory. \nTest Name \nIn Range \n1GF-I \n151 \nFSH \n3.7 \nLH \n4.1 \nPROLACTIN \n2.6 \nPROGESTERONE \n1.1 \nDHEA SULFATE \n182 \nTESTOSTERON,FR/TOT,LCMSMS \nTESTOSTERONE, TOTAL \n188 \nL \n250-1100 ng/dL \nOut of Range \nReference Range \n87-Z25 ng/mL \n1.6-8.0 mIU/nL \n1.5-9.3 miU/mL \n2.0-18.0 ng/nL \n<1.4 ng/nL \n25-240 mcg/dL \nTotal Testosterone was measured by LCMSMS. The LCMSMS method \ncorrelates well with our extraction/RIA method. \n% FREE TESTOSTERONE \n1.94 \nTESTOSTERONE, FREE \n,36.5-)\nMTHER,DNA MUTATION,NY \nsee note A \nRESULT: POSITIUE FOR 2W0 COPIES OF THE C677T ) \nMUTATION \nDNA testing indicates this individual is \nhomozygous for the C6777 mutation and does not \nhave the A1298C mutation. This has been associated \nwith an increased risk for hyperhomocysteinemia \nand vascular diseases. Consider genetic counseling \nand DNA testing for at-risk members. \n1.5-2.2 h \n35.0-155.0 pg/mL \nLab \nTBR \nTBR \nTBR \n7BR \nTBR \nTBR \nQNI \nEPSTE1N,JEFFREY - K4671284 \nPage 1 - Continued on Page 2 \nlint, ken liassistics, \nIns nil •I anictotnt hint /tannins ,,,,, art thr \nit hilt auy.Nal Inentsgan4 \nIll \nsave. er 11N1 \nAMD \nCM, \naveva P b Iltitill\n... [truncated, 2022 chars — for the full page use /api/corpus/document/EFTA00727570/0 or ?id=EFTA00727570&page=0]", "char_count": 2022}, {"efta_number": "EFTA00727570", "page_number": 1, "text_content": "Quest \nDiagnostic \nQUEST DIAGNOSTICS INCORPORATED \nPATIENT INFORMATION \nEPSTE1N,JEFFREY \nDOB: 01/20/1953 AGE: 57 \nREPORT STATUS PARTIAL \nREPRINT \nORDERING PHYSICIAN \nGENDER: M FASTING: \nSPECIMEN INFORMATION \nCLIENT INFORMATION \nSPECIMEN: X4671284 \nT11686 \n10013650 \nCOLLECTED: 03/03/2010 \n11:50 \nREPORTED: \n03/09/2010 \n17:30 \nTest Name \nIn Range \nOut of Range \nReference Range \nLaboratory testing supervised and results \nmonitored by U.M. Pratt, Ph.D., FACIIIG. \nDirector. Molecular Genetics. \nHyperhomocysteinemia is a risk factor for arterial \ndisease and venous thrombosis. Homocystelne levels \nare affected by nutritional and genetic factors. \nSince NTHFR is involved in methyiation of \nhomocysteine to methionine, individuals with \nMTHFR gene mutations that reduce enzyme activity \nmay develop hyperhoncystelnemia and thus be at risk \nfor vascular disease. \nThe C677T and A1298C mutations are detected by \nsignal amplification of the MTHFR gene by allele-\nspecific hybridizations and cheniluninescent \ndetection of hybridized probes. Since genetic \nvariation and other factors can affect the accuracy \nof direct mutation testing, these results should be \ninterpreted in light of clinical and familial data. \nThis test was developed and its performance \ncharacteristics have been determine-it by Quest \nDiagnostics Nichols Institute, Chantil ly, UA. \nIt has not been cleared or approved by the U.S. \nFood and Drug Administration. The FDA has determined \nthat such clearance or approval is not necessary. \nPerformance characteristics refer to the analytical \nperformance of the test. \nESTRADIOL.ULTRASEN.LCKSMS \nPENDING \nPERFORMING LABORATORY INFORMATION: \nAMD Quest Diagnostics Nichols Chantilly 14225 Newbrook ➢rive Chantil ly UA 20151 \nLaboratory Director: Kenneth Sisco. MD,PhD CLIA No: 4900221801 \nQNI Quest Diagnostics, Nichols Institute 33608 Ortega Highway San Juan Capistrano CA 92690 \nLaboratory Director: Dr. Jon M. Nakamoto CLIA No: 05110643352 \nIBR Quest Diagnostics One Malcolm Avenu\n... [truncated, 2341 chars — for the full page use /api/corpus/document/EFTA00727570/1 or ?id=EFTA00727570&page=1]", "char_count": 2341}, {"efta_number": "EFTA00727570", "page_number": 2, "text_content": "Quest \nDiagnostics \nQUEST DIAGNOSTICS INCORPORATED \nCLIENT SERUICE 800.631.1390 \nSPECIMEN INFORMATION \nSPECIMEN: X4666434 \nREQUISITION: \nCOLLECTED: 03/03/1010 \n08:20 \nRECEIUED: \n03/03/2010 \n20:43 \nREPORTED: \n03/08/2010 \n08:32 \nPATIENT INFORMATION \nESPSTEIN,JEFFREY \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nPHONE: 212.772.9416 \nREPORT STATUS FINAL \nREPRINT \nORDERING PHYSICIAN \nCLIENT INFORMATION \nT11886 \nWOODSON MERRELL, M.D. \n44 E 67TH STREET \nNEW YORK, NY 10065 \n10013650 \nThe original copy of this report was printed on: 03/05/2010 at 08:16 \nTest Name \nLEAD,BL000 \nIn Range \nOut of Range \nReference Range \n<3 \n<10 mcg/dL \nBlood lead levels in the range of 5-9 mcg/dL have been \nassociated with adverse health effects in children aged \n6 years and younger. \nIndustrial Exposure: <40 mcg/dL \nncg/dL = mcg/100g for OSHA \n(refer to current governmental regulations for exposure \ncriteria) \nMERCURY, BLOOD \nARSENIC,BL00D \n5 \n<=10 mcg/L \n4 \n<23 mcg/L \nUrine is usually the best specimen for the analysis \nof Arsenic in body fluids. Blood levels tend to be \nlow even when urine concentrations are high. \nPERFORMING LABORATORY INFORMATION: \nAND Quest Diagnostics Nichols Chantilly 14025 Newbrook Drive Chantilly VA 20151 \nLaboratory Director: Kenneth Sisco, MD.PhD CLIA No: 49D0221801 \nTOR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 \nLaboratory Director: William E. Tarr, M.D. CLIA No: 31D0696246 \nESPSTEIN,JEFFREY - K4666434 \nPage 1 - End of Report \nIt'll, lout Itiliostics, IM asseciilif 10$0 Ahl \naIsociatid Putt tia,,eslu, \n, \nItal\".0\" , IC 14O 0,,,,,IIIrs :flOrIN,rIt$ \nIll ritIII risrtiti. OI.OPIt4 \n2/1I \nLab \nTBR \nAMU \nAMD \nCC2 \nevivit BIN ionsia 7/7 \nEFTA00727572\n", "char_count": 1689}, {"efta_number": "EFTA00727570", "page_number": 3, "text_content": "ak Quest \nfa? Diagnostic: \nOMs: \n: ACUIOSIA CS INCORPORATED \nCLIENT SERVICE PO O. G31 . I j 90 \nSPECIMEN INFORMATION \nSPECIMEN: F7579815 \nREQUISITION: \nCOLLECTED: 03/03/2010 \nRECEIVED: \n03/03/2010 \nREPORTED: \n03/05/2010 \n11:50 \n21:49 \n10:31 \nPAT I FAIT INFORMATION \nEPSTEIN, JEFFREY \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nPHONE: 212.750.9895 \nREPORT STATUS FINAL \nORDERING PHYSICIAN \nCL: ENT INFORMATION \nT11886 \nWOODSON MERRELL, M.D. \n44 F. 67TH STREET \nNEW YORK, NY 10065 \n10013650 \nTest Name \nCALCIUM \nFTR,INTACT \nInterpretive Guide \nNormal Parathyroid Function \nHypoparathyroidism \nPrimary Hyperparathyroidism \nSecondary Hyperparathyroidism \nTertiary Hyperparathyroidism \nNon-Parathyroid Hypercalcemia \nIn Range \nIntact PT \nNormal \nLow or Low Normal \nNormal or High \nHigh \nHigh \nLow or Low Normal \nOut of Range \nH \nH\n6)\nPERFORMING LABORATORY INFORMATION: \nYBR Ousel Diagnostics one Malcolm Avenue Teterboro \nMIA NO; 3100696246 \nReference Range \n8.6-10.2 mg/dL \n10-65 pg/mL \nCalcium \nNormal \nLow \nHigh \nNormal or Low \nHigh \nHigh \nNJ 07608 Laboratory Director: William E. Tarr. \nLab \nTSR \nTBR \nEPSTEIN,JEFFREY - F7579815 \nPage 1 - End of Report \nOn.' OHS C.W404. 71• owe roc isso •••t \nANOPNI Omatomften M, \nau um eyNoN•ittaume Derma • t (Wu Oontscs WOCIWOW \n'Wt. \ntaro*, =NON% knee SOB $0 \n1. ANN \nEFTA00727573\n", "char_count": 1323}, {"efta_number": "EFTA00727570", "page_number": 4, "text_content": "O4\nQuest \n4 \nDiagnostics \nDate of Report 03/06/2010 \nPatient Name: \nJeffrey Epstein \nIdentification Number: \nAge: 57 \nSex: M \nIntact Parathyroid \nHormone \nTest No. 1222A \nDate Received: 03/03/2010 \nAccession a F7579815 \nResults (Please refer to \nthe official Medical Report) \nIntact PTH 88.90 pg/mL \n(Normal Range 10 - 85 pg/mL) \nTotal Calcium 10.40 mg/dL \n(Female Range 8.5. 10.3 mg/dc• \nMale Range 8.7 • 10.4 mg/cIL• I \nLegend \nNormal \nIndeterminate \nSecondary \nHyperparathyroidism \nPrimary \nHyperparathyroidism \nHypoparathyroidism \nNon-Parathyroid \nHypercalcemia \n(Lest Diagnostics \nOne Malcolm Avenue \nTeentoro, New Jersey 076C6- 1070 \n8CC1.631.B90 \n1-11886 10013650 \nWOODSON MERRELL, M.D. \n44 E 67th Street \nNew York, NY 10065 \n10003 \n0000 \n0000 \n7000 \n0303 \n5000 \n4000 \nNCO \n900 \n000 \n700 \nNO \nS00 \n400 \nE \n'v. \n300 \nen \na. \ne \n200 \n0 \nI \n1\nos\na°\n70 \n«pg \n60\nGO \n40 \nti \nto \n9 \n8 \nNote: The reference range on the graph may 6 \ndiffer from the reference range cited for this \n5\npatient. The comparison data set on the back \n4\nof this report includes both male and female \npatients. The reference ranges for calcium on \n3 \nthe graph are those that would be applied to \nan adult patient where sex was unspecified. \nuest Tar ch.\nIntact Parathyroid Hormone \nOrdering Physician: \nRoute: I001.4,50 \nAccount Number. \nI'I INK6 \nC\n10\n40 \n60 \n10 \n10.0 \n140 \n16,0 \nC 9201 Quest Diagnostics Incorporated. All rights reserved. \nGuest Quest Diagnostics, the associated logo end NI associated Quest Dognostics marks are the vedemerks of Quest Diagnostics Margo/aced. \nCalcium (mg/dL) \nEFTA00727574\n", "char_count": 1588}, {"efta_number": "EFTA00727570", "page_number": 5, "text_content": "Aark Quest \n‘ W \nDiagnostics \nQUEST DIAGNOSTICS INCORPORATED \nCLIENT SERVICE 000.611.1390 \nSPECIMEN INFORMATION \nSPECIMEN: 92116012 \nREQUISITION: \nCOLLECTED: 03/03/2010 \n08:20 \nRECEIVED: \n03/03/2010 \n19:57 \nREPORTED: \n03/08/2010 \n08:16 \nATIHNT :NFOHMAT:ON \nEPSTEIN, JEFFREY \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nPHONE: 212.772.9416 \nREPORT STATUS FINAL \nORDERING PHYSICIAN \nC!JENT INFORMATION \nT11886 \nWOODSON MERRELL, M.D. \n44 E 67TH STREET \nNEW YORK, NY 10065 \n10013650 \nTest Name \nMAGNESIUM \nTSH,3RD GENERATION \nTHYROID PANEL \nT4,TOTAL \nPlease note new reference range. \nT3 UPTAKE \n32 \nT4,FREE,CALCULATED \n3.0 \nIn Range \n1.8 \n1.77 \nCR, TOTAL \n9.4 \nOut of Range \nReference Range \n1.5-2.5 mg/dL \n0.40-4.50 mIU/L \n4.5-12.5 mcg/dL \n22-35 Percent \n1.4-3.8 Units \n44-196 U/L \nLab \nTBR \nTBR \nTBR \nTBR \nEPSTEIN,JEFFREY - 92116012 \nPage 1 - Continued on Page 2 \n3.mt Oary On.mmc nn mm wed ov..km al onmom Cum flummt‘i mats am omPOOMMSOOmmlOmmefles C. Gant Datcrom \ncmommi Al miltunemd OLMMILML elm les MX SCH. MCA) \nEFTA00727575\n", "char_count": 1033}, {"efta_number": "EFTA00727570", "page_number": 6, "text_content": "link Quest \nDiagnosticsi\nPAIIEN't :Nr.,RMATICti \nEPSTEIN,JEFFREY \nDIAGNOSTICS INCORPORATED \nORDERING PHYSICIAN \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nREPORT STATUS FINAL \nMEN INFORMATION \nCIHEN: 92116012 \nLECTED: 03/03/2010 \n08:20 \nORTED: \n03/08/2010 \n08:16 \nCLIENT INFORMATION \nT11886 \n10013650 \nest Name \nIn Range \nOut of Range \nReference Range \nLab \n!S/HDL/TIBC W FER RFX/FRUCTOSAMINE \nTBR \nNE \n246 \n(. \n190-270 umol/L\n104\n \nH \n65-99 mg/dL \nFRUCTOSAMI \nGLUCOSE,PASTING \nSODIUM \n140 \n135-146 mmol/L \nPOTASSIUM \n4.4 \n3.5-5.3 mmol/L \nCHLORIDE \n105 \n98-110 mmol/L \nCARBON DIOXIDE \n24 \n21-33 mmol/L \nUREA NITROGEN \n18 \n7-25 mg/dL \nCREATININE \n0.94 \n0.76-1.46 mg/dL \nBUN/CREATININE RATIO \nNOTE \n6-22 \nBun/Creatinine ratio is not reported when the Bun and \nCreatinine values are within normatt ld itS. \nURIC ACID \nPHOSPHORUS \nCALCIUM \nCHOLESTEROL, TOTAL \nHDL CHOLESTEROL \nCHOLESTEROL/HDL RATIO \nLDL CHOL, CALCULATED \nSee footnote 1 \nTRIGLYCERIDES \nPROTEIN, TOTAL \nALBUMIN \nGLOBULIN, CALCULATED \nA/G RATIO \nBILIRUBIN, TOTAL \nBILIRUBIN, DIRECT \nALKALINE PHOSPHATASE \nGGT \nAST \nALT \nLD \nIRON, TOTAL \nTIBC \nTRANSFERRIN SATURATION \n8.6 \n3.3 \n10.0 \n200 \n111 \n7.4 \n4.6 \n2.8 \n1.6 \n0.7 \n0.1 \n64 \n12 \n21 \n19 \n152 \n70 \n314 \n22 \nH \n4.0-8.0 mg/dL \n2.5-4.5 mg/dL \n8.6-10.2 mg/dL \n125-200 mg/dL \nl?.)  \n>=40 mg/dL \n6.1 \nH \n< = 5.0 \n<130 mg/dL \n<150 mg/dL \n6.2-8.3 g/dL \n3.6-5.1 g/dL \n2.1-3.7 g/dL \n1.0-2.1 \n0.2-1.2 mg/dL \n< = 0.2 mg/dL \n40-115 U/L \n3-85 U/L \n10-35 U/L \n9-60 U/L \n120-250 U/L \n45-170 mcg/dL \n250-425 mcg/dL \n20-50 t \n;TEIN,JEFFREY - 92116012 \nPage 2 - Continued on Page 3 \nO,1µ Omni Ougromk nrosioon \nvo •••••:(al Omni 0••••••••• van ttttt usfeowat or• Wet Permits vIlastastanias Norway! Linos eimmil ODY0110.0111. RIMS %Of Sat I IWO \nEFTA00727576\n", "char_count": 1754}, {"efta_number": "EFTA00727570", "page_number": 7, "text_content": "Ank Quest \nDiagnosti9 \nPAT I ENT INFORMATION \nEPSTEIN, JEFFREY \nQUEST DIAGNOSTICS INCORPORATED \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nSPECIMEN I NPORMAT 70N \nSPECIMEN: 92116012 \nCOLLECTED: 03/03/2010 \n08:20 \nREPORTED: \n03/08/2010 \n08:16 \nREPORT STATUS FINAL \nORDERING PHYSICIAN \nCL IN INFORMATION \nT11886 \n10013650 \nTeat Name \nIn Range \nOut of Range \nReference Range \nLab \nCBC (INCLUDES DIFF/PLT) \nWBC \n5.3 \n3.8-10.8 Thous/mcL \nRBC \n5.06 \n4.20-5.80 Mill/mcL \nHEMOGLOBIN \n15.0 \n13.2-17.1 g/dL \nHEMATOCRIT \n44.8 \n38.5-50.0 % \nMCV \n88.5 \n80.0-100.0 fL \nMCH \n29.6 \n27.0-33.0 pg \nMCHC \n33.4 \n32.0-36.0 g/dL \nRDW \n13.4 \n11.0-15.0 % \nPLATELET COUNT \n289 \n140-400 Thous/mcL \nMPV \n7.9 \n7.5-11.5 fL \nTOTAL NEUTROPHILS,% \n49.7 \n38-80 % \nTOTAL LYMPHOCYTES,% \n34.9 \n15-49 % \nMONOCYTES,% \n7.5 \n0-13 % \nEOSINOPHILS,% \n7.2 \n0-8 % \nBASOPHILS,% \n0.7 \n0-2 % \nNEUTROPHILS,ABSOLUTE \n2634 \n1500-7800 Cells/mcL \nLYMPHOCYTES,ABSOLUTE \n1850 \n850-3900 Cells/mcL \nMONOCYTES,ABSOLUTE \n398 \n200-950 Cells/mcL \nEOSINOPHILS,ABSOLUTE \n3B2 \n15-550 Cells/mcL \nBASOPHILS,ABSOLUTE \n37 \n0-200 Cells/mcL \nDIFFERENTIAL \nAn instrument differential was performed. \nURINALYSIS, COMPLETE \nCOLOR \nYellow \nYellow \nAPPEARANCE \nCloudy \n* \nClear \nGLUCOSE,QL \nNegative \nNegative mg/dL \nBILIRUBIN,URINE \nNegative \nNegative \nKETONES \nNegative \nNegative mg/dL \nSPECIFIC GRAVITY \n1.024 \n1.001-1.035 \nBLOOD \n(1+) * \nNegative \nPH \n5.5 \n5.0-8.0 \nPROTEIN, TOTAL,QL \nNegative \nNegative mg/dL \nNITRITE \nNegative \nNegative \nLEUKOCYTE ESTERASE \nNegative \nNegative \nSQUAMOUS EPITHELIAL CELLS \nNone Seen \ncor=6 cells/hpf \nWBC \nNone Seen \n<or=5 cells/hpf \nBACTERIA \nNone Seen \nNone Seen /hpf \nRBC \nHYALINE CASTS \nNone Seen t ill i\n) \ncor=3 cells/hpf \nNone Seen /lpf \nTBR \nTBR \nEPSTEIN,JEFFREY - 92116012 \nPage 3 - Continued on Page 4 \nOast Pupil Depron em stint aelev \n...oat 4.etiOinsevc• nits, re in. rafoisarkt C mesa...y.4 viltest \nMori \nCINIXONTI. P.0•01 \nSCX .1.05 \nEFTA00727577\n", "char_count": 1930}, {"efta_number": "EFTA00727570", "page_number": 8, "text_content": "oft Quest \nDiagnostics \nQUEST DIAGNOSTICS INCORPORATED \nSPECIMEN INFORMATION \nSPECIMEN: 92116012 \nCOLLECTED: 03/03/2010 \nREPORTED: \n03/08/2010 \n08:20 \n08:16 \nPATIENT INFORMATION \nEPSTEIN, JEFFREY \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nREPORT STATUS FINAL \nORDERING PHYSICIAN \nCLIENT INFORMATION \nT11886 \n10013650 \nTest Name \nIn Range \nOut of Range \nReference Range \nLab \nVITAMIN B12 . FOLATE \nVITAMIN B12,SERUM \n0\n/2)  \n200-1100 pg/mL \nPlease note: although the reference range for Vitamin B12 \nis 200-1100 pg/mL, it has been reported that between 5 and \n10% of patients with values between 200 and 400 pg/mL may \nexperience neuropsychiatric and hematologic abnormalities \ndue to occult 812 deficiency; less than 1% of patients with \nvalues above 400 pg/mL will have symptoms. \nFOLATE,SERUM \n10.6 \n> 5.4 ng/mL \nNormal: \n>5.4 \nBorderline: 3.4-5.4 \nLow: \n<3.4 \nCARDIO CRP (R) \n0.8 \nmg/L \nLow relative cardiovascular risk according to AHA/CDC \nguidelines. \nSee footnote 2 \nTBR \nTBR \nPSA,TOTAL \n0.54 \n<=4.0 ng/mL \nTBR \nSee footnote 3 \nAPOLIPOPROTEIN A-1.B \nTBR \nAPOLIPOPROTEIN Al \n117 _. \n94-176 mg/dL \nAPOLIPOPROTEIN B \n107 \n52-109 mg/dL \nAPOLIPOPROTEIN B/A1 RATIO \n0.91 \nBelow average risk: \n<0.29 \nAverage risk: \n0.29-1.30 \nAbove average risk: \n>1.30 \nHEMOGLOBIN A1C \nH \nPercent \nTBR \nReference Range: Non Diab \n6.0% \nHOMOCYSTEINE,CARDIO \nTBR \nHOMOCYSTEINZ \ne_1) \n<11.4 MICROmol/L \nEPSTEIN,JEFFREY \n92116012 \nPage 4 - Continued on Page 5 \nOwn bag D•ren. \nasm.:0.000 roc 0 \n,,,,, 0411,.01 0.10 .0(. 10,4 et 0e PeltankSO 00014.00Cs t. .el0qnneis le0rwilltd AI nein Mr.*/ mom Kn. \nSu,: • IMP: \nEFTA00727578\n", "char_count": 1612}, {"efta_number": "EFTA00727570", "page_number": 9, "text_content": "Ain Quest \nCP ), Diagnostics \nS \nQUEST DIAGNOSTICS INCORPORATED \nSPECIMEN INFORMATION \nSPECIMEN: 92116012 \nCOLLECTED: 03/03/2010 \nREPORTED: \n03/08/2010 \n08:20 \n08:16 \nPAT:ENT INFORMATION \nEPSTEIN, JEFFREY \nDOB: 01/20/1953 AGE: 57 \nGENDER: M FASTING: Y \nREPORT STATUS FINAL \nORDERING PHYSICIAN \nCLIENT INFORMATION \nT11886 \n10013650 \nTest Name \nIn Range \nOut of Range \nReference Range \nLab \nVITAMIN D,25-OH, LC/MS/MS \nVITAMIN D, 25-OH, TOTAL \n42 \n20-100 ng/mL \nVITAMIN D, 25-OH, D3 \n42 \nng/mL \nVITAMIN D, 25-OH, D2 \n<4 \nng/mL \n25-OHD3 indicates both endogenous production and \nsupplementation. 25-OHD2 is an indicator of exogenous sources \nsuch as diet or supplementation. Therapy is based on \nmeasurement of Total 25-OHD, with levels <20 ng/mL indicative \nof Vitamin D deficiency, while levels between 20 ng/mL and \n30 ng/mL suggest insufficiency. Optimal levels are >30 ng/mL. \nTBR \nMAGNESIUM,RBC \n4.6 \n4.0-6.4 mg/dL \nAMD \nFOOTNOTE(S): \n1 \nDesirable range is <100 mg/dL for patients with coronary \nheart disease (CHD) or diabetes, and <70 mg/dL for diabetic \npatients with known CHD. \n2 \nFor Ages >17 Years: \n3 \nCCRP mg/L \nRisk according to AHA/CDC guidelines \n<1.0 \nLow cardiovascular risk \n1.0 - \n3.0 \nAverage cardiovascular risk \n3.1 - 10.0 \nHigh cardiovascular risk \n>10.0 \nPersistent elevations may represent \nnon-cardiovascular inflammation \nThis test was performed using the Siemens (Bayer) \nchemiluminescent method. Values obtained from different \nassay methods cannot be used interchangeably. PSA levels, \nregardless of value, should not be interpreted as absolute \nevidence of the presence or absence of disease. \nPERFORMING LABORATORY INFORMATION: \nAMD Quest Diagnostics Nichols Chantilly 14225 Newbrook Drive Chantilly VA 20151 \nLaboratory Director: Kenneth Sisco. PID.PhD CLIA NO: 4900221801 \nTBR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 laboratory Director: William E. Tarr, M.D. \nCLIA No: 31D0696246 \nEPSTEIN,JEFFREY - 92116012 \nPage 5 - End of Report \nOWE IA.: Our,' \n•\n... [truncated, 2150 chars — for the full page use /api/corpus/document/EFTA00727570/9 or ?id=EFTA00727570&page=9]", "char_count": 2150}, {"efta_number": "EFTA00727570", "page_number": 10, "text_content": "441,lk Quest \ne\na, Diagnostics \nQUEST DIAGNOSTICS INCORPORATED \nCLIENT SERVICE 800.631.1390 \nSPECIMEN INFORMATICN \nSPECIMEN: F7579848 \nREQUISITION: \nCOLLECTED: \nRECEIVED: \nREPORTED: \nPATIENT INFORMATION \nEPSTEIN, JEFFREY \nDOB: 01/20/1953 AGE: 57 \nREPORT STATUS incbutr., \nORDERING PHYSICIAN \nGENDER: M FASTING: Y \nCLIENT INFORMATION \nT11886 \n10013650 \nPHONE: 212.772.9416 \nWOODSON MERRELL, M.D. \n44 E 67TH STREET \n03/03/2010 \n08:20 \n03/03/2010 \n21:52 \n03/08/2010 \n08:16 \nNEW YORK, NY 10065 \nTeat Name \nINSULIN, FREE \nIn Range \nOut of Range \nReference Range \n7.8 \n1.5-14.9 uIU/mL \nInsulin levels vary widely in specimens taken from \nnon-fasting individuals. \nPREPORIRI140 LABORATORY INFORMATION: \nQNI Quest Diagnostics, Nichols Institute 33608 Ortega Highway San Juan Capistrano CA 92690 \nLaboratory Director: Dr. Jon M. Nakaaoto CLIA NO: 0500643352 \nLab \nQNI \nEPSTEIN,JEFFREY - F7579848 \nPage 1 - End of Report \nWs, Cll 04O0*(1 Pe 41.4%,•Lte \nNIS (fri (J•r«. Is west aro IN • vsglanaNso/ Gre0horpsocs \n0.•ullirencs lwargatom Al ere NSW 0.9 00)1130SPITL Rona i as Sell una \nEFTA00727580\n", "char_count": 1086}]}